PEAK6 Investments L.P. Raises Position in China Cord Blood Corporation (CO)

PEAK6 Investments L.P. increased its position in China Cord Blood Corporation (NYSE:CO) by 8.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 175,657 shares of the medical research company’s stock after buying an additional 13,657 shares during the quarter. PEAK6 Investments L.P. owned about 0.15% of China Cord Blood worth $1,953,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Wells Fargo & Company MN raised its position in China Cord Blood by 1,260,105.6% in the third quarter. Wells Fargo & Company MN now owns 226,837 shares of the medical research company’s stock valued at $2,522,000 after purchasing an additional 226,819 shares during the period. Trexquant Investment LP purchased a new position in China Cord Blood in the third quarter valued at about $236,000. Dynamic Technology Lab Private Ltd purchased a new position in China Cord Blood in the third quarter valued at about $944,000. Ameriprise Financial Inc. purchased a new position in China Cord Blood in the third quarter valued at about $3,881,000. Finally, SG Americas Securities LLC raised its position in China Cord Blood by 131.2% in the third quarter. SG Americas Securities LLC now owns 231,204 shares of the medical research company’s stock valued at $2,571,000 after purchasing an additional 131,204 shares during the period. 9.13% of the stock is currently owned by institutional investors and hedge funds.

Shares of China Cord Blood Corporation (NYSE:CO) traded down $0.18 during midday trading on Thursday, hitting $10.53. The stock had a trading volume of 172,900 shares, compared to its average volume of 317,266. China Cord Blood Corporation has a twelve month low of $4.27 and a twelve month high of $14.95. The stock has a market capitalization of $1,291.67, a price-to-earnings ratio of 30.60 and a beta of 0.88.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2017/12/07/peak6-investments-l-p-raises-position-in-china-cord-blood-corporation-co.html.

About China Cord Blood

China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee.

Institutional Ownership by Quarter for China Cord Blood (NYSE:CO)

Receive News & Ratings for China Cord Blood Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Cord Blood Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply